Plasma symmetric dimethylarginine as a metabolite biomarker of severe acute ischemic stroke

IntroductionAfter severe ischemic stroke (IS), circulating levels of symmetric dimethylarginine (SDMA) increase. We investigated the early dynamics of SDMA in stroke to potentially aid with prehospital identification of severe IS from hemorrhagic stroke (HS).MethodsWe performed targeted mass spectro...

Descripción completa

Detalles Bibliográficos

Autores principales:	Saana Pihlasviita, Olli S. Mattila, Tiina Nukarinen, Markku Kuisma, Heini Harve-Rytsälä, Juhani Ritvonen, Gerli Sibolt, Sami Curtze, Daniel Strbian, Mikko Pystynen, Turgut Tatlisumak, Perttu J. Lindsberg
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2024-11-01
Colección:	Frontiers in Neurology
Materias:	stroke diagnosis acute management biomarkers SDMA
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1472424/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!